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FOCUS: NONCOVALENT INTERACTIONS
Mass Spectrometric Determination
of Association Constants of Adenylate Kinase
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Noncovalent complexes between chicken muscle adenylate kinase and two inhibitors, P1,P4-
di(adenosine-5')tetraphosphate (Ap4A) and P1,P5-di(adenosine-5') pentaphosphate (Ap5A),
were investigated with electrospray ionization mass spectrometry under non-denaturing
conditions. The nonconvalent nature and the specificity of the complexes are demonstrated
with a number of control experiments. Titration experiments allowed the association constants
for inhibitor binding to be determined. Problems with concentration dependent ion yields are
circumvented by a data evaluation method that is insensitive to the overall ionization
efficiency. The Ka values found were 9.0  10
4 M1 (Ap4A) and 4.0  107 M1 (Ap5A),
respectively, in very good agreement with available literature data. (J Am Soc Mass Spectrom
2003, 14, 442–448) © 2003 American Society for Mass Spectrometry
Soft ionization mass spectrometry (MS), in particu-lar matrix-assisted laser desorption/ionization(MALDI) and electrospray ionization (ESI), is well
known for its ability to bring high molecular weight
biomolecules into the gase phase and to even preserve
noncovalent complexes [1–10]. Besides its established
applications, a recurring question concerns the applica-
bility of mass spectrometry to measuring noncovalent
interaction strengths [11]. There are different ap-
proaches to measure the interaction strengths in the gas
phase as well as in the liquid phase. In the former case,
the mass spectra should ideally directly represent the
solution phase chemistry. Gas-phase methods include
cone voltage driven dissociation (called the “VC50”
method) [12, 13], collision-induced dissociation [14, 15],
guided ion beam tandem mass spectrometry [16, 17],
blackbody infrared radiative dissociation [18, 19] and
heated capillary dissocation [20, 21].
Some mass spectrometric studies have been reported
in the literature for the determination of noncovalent
interaction strengths. There are three basic methods to
determine association constants that are reflective of
those in solution: first, it is possible to record “melting
curves” by raising the temperature of the analyte solu-
tion and to use MS to determine the percentage of intact
complexes. Cheng et al. analyzed complementary DNA
strands [22] and Fa¨ndrich et al. studied the chaperone
GimC/prefolding homologue complex [13] with this
method. Second, competition experiments can be used
to evaluate the stability of noncovalent complexes. In
Jørgensen’s method [23, 24], the relative intensities of
the free host and the different complexes were used,
whereas Kempen et al. employed the known concentra-
tion of a reference complex to determine the concentra-
tion of an unknown complex [25]. Third, a titration of a
host with a guest (or vice versa) can be used. In this
case, the mass spectrometric signals should accurately
represent the concentrations of the species in solution.
The titration method is documented in a number of
publications, all of them convincingly showing the
successful use of mass spectrometry for the quantitative
determination of noncovalent binding constants of pro-
teins and small molecules [26–33]. This aspect was the
main focus in most previous research; the specificity of
the noncovalent interaction was often not verified.
However, it is essential to establish that the analyzed
complexes are neither gas phase clusters nor the result
of unspecific adduct formation in solution. Another,
equally important aspect concerns the ionization effi-
ciency of the species appearing in the mass spectra. If a
calibration curve is first recorded for one species to
evaluate its concentration, the total ionization efficiency
must remain the same during a subsequent titration
experiment. For some systems this may be true, but
often, the total ionization efficiency drops as the titra-
tion proceeds. Thus, a measurement that is independent
of total ionization efficiency would be preferable.
In an effort to develop soft ionization mass spectro-
metry into a more accepted and robust method for
studying noncovalent interactions quantitatively, we
present a method where only the relative signals of a
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protein and a noncovalent protein-inhibitor complex
are determined. In other words, a varying overall
ionization efficiency will not affect the results. Further-
more, we present a set of control experiments to verify
the specificity of the complex and to rule out any
unspecific or gas phase adducts. The system studied in
this work was adenylate kinase (AK) from chicken
muscle and its two noncovalent inhibitors P1,P4-di(ade-
nosine-5')tetraphosphate (Ap4A) and P1,P5-di(ade-
nosine-5')pentaphosphate (Ap5A). AK is a phospho-
transferase that catalyzes the transfer of the
-phosphate group of magnesium-adenosine-triphos-
phate (MgATP) to adenosine-monophosphate (AMP)
and therefore plays an important role in the energy
metabolism of cells [34]. There are five major types of
AK: AK1 (from cytosols of mammalian or vertebrate
muscles, with c, h, p, and r designating chicken, human,
porcine, and rabbit, respectively), AKe (from Escherichia
coli), AKy (from yeast), AK2 (from mammalian mito-
chondrial intermembrane space), and AK3 (from mam-
malian mitochondrial matrix, specific to GTP instead of
ATP). AK1 differs from AKe and AKy in lacking a
30-residue loop near position 132 [35]. In all other
aspects of structure and function, AK1 and AKe show
high similarities [36]. AK has a molecular weight of 21.6
kDa and its inhibitors are well studied. It is thus a
well-suited model system for the studies presented
here.
Experimental Section
Instrumentation All experiments were conducted on a
prototype electrospray orthogonal injection time-of-
flight mass spectrometer from Agilent (Palo Alto, Cali-
fornia, USA). It consists of a commercial atmospheric
pressure electrospray interface (Agilent), two skim-
mers, and an octapol ion guide for collisional cooling.
The ions are extracted orthogonally by a pulsed extrac-
tion field at a repetition rate of 4 kHz. The ions are
guided via a single stage reflectron to the detector (ETP
Electron Multipliers Pty Ltd., Ermington, Australia).
The detector signal is amplified and digitized with a
computer (Hewlett Packard, Palo Alto, California, USA)
at a sampling frequency of 250 MHz. Infusion rates of 3
to 5 l/min with a pneumatically assisted ESI source
(“ion spray”) were used. The spray potentials were
between 2700 and 3000 V. The source conditions of the
instrument were optimized for the transfer of high
molecular weight ions and for gentle desolvation con-
ditions by adjusting the different source and transfer
potentials. For low energy dissociation experiments the
voltage between sampling cone and skimmer was in-
creased, from 32 V to 140 V, which is sufficient to
dissociate noncovalent complexes. Spectra were re-
corded with a repetition rate of 4kHz and a couple of
100'000 spectra were summed and transferred to a PC
for further processing.
Materials and Methods
Adenylate kinase (M  21689 Da) from chicken muscle
was obtained from Sigma (St. Louis, MA, USA) and
used for the titration experiments without purification.
However, even in “essentially salt free” AK samples, a
batch dependent amount of magnesium was present.
The sample were thus treated by adding EDTA, primar-
ily to allow comparison of our results with literature
data. The solvent for all samples was water. NH4AcO
and (HNEt3)HCO3 were used to buffer the protein-
inhibitor solutions; these are well known for conserving
noncovalent interactions in ESI [37]. The titration sam-
ples contained between 8.8 and 9.0 M AK (depending
on the volume of added inhibitor), 0 to 9.6 M P1,P5-
di(adenosine-5')pentaphosphate (Ap5A) or 0 to 12 M
P1,P4-di(adenosine-5')tetraphosphate (Ap4A), 50mM
(HNEt3)HCO3, and 500 M EDTA. Inhibitors were from
Fluka (Buchs, Switzerland) and from Sigma (St. Louis,
MO/USA), respectively. 8-N3-ATP was obtained from
Biolog Life Science Institute, Bremen, Germany.
AK was denatured in four different ways. A solution
containing 10 M AK in 10mM NH4AcO buffer was
incubated with 50% MeOH (HPLC grade) or 5% AcOH
(reagent grade), prior as well as after adding the 10M
Ap5A. For the low energy dissociation experiments
described in Figure 1 (see below), several different
solutions were used, including 107M AK/10M
Ap5A in 50mM (HNEt3)HCO3 buffer and 10M AK/
20M Ap5A in 5mM NH4AcO buffer.
Figure 1. ESI mass spectra (charge state 5) of 10M AK and
10M Ap5A in 50mM (HNEt3)HCO3 with a) soft ionization
conditions and b) harsher ionization conditions (increased cone
voltage) leading to low energy dissociation.
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AK was covalently modified in its binding pocket
according to a slightly adapted method originally
published by Olcott [38] and David [39]. 0.3 l 5mM
8-N3-ATP in 10mM NH4AcO, 0.5l 20mM MgCl2,
12l 250M AK in 10mM NH4AcO and 87 l 50mM
Tris/HCl (pH  7.2) were mixed on ice and incu-
bated for 30 seconds. The solution was exposed to UV
radiation at a wavelength of 254 nm (Westinghouse
Electric Corp. Fluorescent & Vapor Lamp Division,
Broomfield, N.J., USA) for 75 seconds. Another 0.3 l
5mM 8-N3-ATP in 10mM NH4AcO was added and
again exposed to the UV radiation for 75 seconds. The
Tris/HCl buffer was exchanged with a NAP-5 gel
permeation column (Pharmacia Biotec AB, Sweden)
to 10mM NH4AcO. The reaction was incomplete, but
the activity of the treated AK sample was probed by
an essay described by Wallimann et al. [40] and was
found to be reduced by 25%  5%. The mass of the
modified AK was 22259 Da.
Data Evaluation Equations 1 through 3 describe the
complex formation of AK with its inhibitor ApXA:
Ka 
AK  ApXA
AK  ApXA
(1)
AK0  AK  AK  ApXA (2)
ApXA0  ApXA  AK  ApXA (3)
where Ka is the association constant, [AK] the concen-
tration of the bare protein, [ApXA] the concentration of
the inhibitor and [AKApXA] the concentration of the
complex. “0” denotes the total concentration of a given
species. Experimentally, we measure the concentration
ratio of the complex and the bare protein, which is
called R below:
R 
AK  ApXA
AK
(4)
These equations can be solved for Ka for known values
of [AK]0 and [ApXA]0 to yield eq 5:
Ka 
R2  R
ApXA0  1  R	  AK0  R
(5)
A more robust, global data evaluation that takes into
account all data points can be achieved by a least
squares fit of the experimental R vs. known [ApXA]0
values to an expression which is obtained by solving the
above equations for R. This yields eq 6, where Ka is the
only adjustable parameter.
R 
1
2   1  Ka  AK0  Ka  ApXA0  4  Ka  ApXA0  Ka  ApXA0  Ka  AK0  1	2
(6)
Particularly for statistical error analysis, the fit de-
scribed in eq 6 is preferable to a Scatchard plot (see, for
example [32]) or other forms of data linearization that
are used for graphical evaluation of protein inhibition.
A similar approach as the one described here was
chosen by Greig et al. [26] who used a fit to a second
order polynomial to determine two dissociaton con-
stants of a BSA–oligonulecotide complex.
In the approach described here, the ratio R of peak
areas for the [AK] and [AKApXA] signals is used to
determine the association constant. A good baseline
correction method is important to obtain reliable re-
sults, in particular when one of the peaks is hardly
visible. Different baseline correction methods were
therefore tested. In the simplest approach, a constant
value was subtracted from the data. In a more refined
method, a line was fitted to the baseline allowing the
correction of a sloping baseline. In the third method, a
linear baseline was calculated for each peak, allowing
for different slopes in the baseline. In the most sophis-
ticated method, an arbitrary mathematical form of the
baseline was allowed. The differences between these
methods were found to be negligible. Therefore the
simplest baseline correction method was used through-
out.
Each titration point was measured five times. The 5
charge state of the bare protein and the complex were
integrated. Other detectable charge states had negligi-
ble signal intensities. The ratio R was calculated for each
spectrum. A least square fit was performed using
equation 5 with Ka as the fitting parameter for the
titration experiment.
Results and Discussion
For analysis of large noncovalent complexes, suitable
conditions must be found where desolvation is suffi-
ciently complete to allow mass resolution of all different
species, but where the noncovalent complex is not
destroyed. This compromise is responsible for the fairly
low S/N ratio, which was found to drop even further
with increasing inhibitor concentration. Figure 2 shows
mass spectra of 8.8 M AK with 8 M Ap4A (Trace a)
and Ap5A (Trace b), respectively. The observed peaks
are all quite broad, probably due to an incomplete
desolvation leading to water and buffer adducts. How-
ever, the signals of free AK and of the complexes are
clearly resolved. Dependent on the sample batch, a
second, less abundant peak for AK and for AKApXA
was detected in some of the spectra. It could not be
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unambiguously identified, but we assume it to be due
to a contamination from a sequence variant of AK. Since
these peaks originate from an AK variant of comparable
activity, we included them in the evaluation of the
titration experiments as well.
If a signal at the mass of a complex is detected by
mass spectrometry, it does not automatically imply that
the complex is indeed noncovalent and specific. There-
fore we performed a number of control experiments to
prove the specificity and the noncovalent nature of the
suggested interaction. Figure 1 shows spectra of AK
with the inhibitor Ap5A at physiological pH. Trace (a)
was recorded with soft ionization and desolvation
conditions preserving the noncovalent complex,
whereas trace (b) represents harsher conditions (in-
creased cone - skimmer voltage) leading to low energy
dissociation of the complex. This data shows the 5
charge state and was recorded using 10 M AK and 10
M Ap5A in 50 mM (HNEt3)HCO3. Identical behavior
was found for other solution conditions, e.g., 10 M
AK, 20 M Ap5A in 5 mM NH4AcO. The complex
always disappeared under harsher interface conditions,
while the protein itself remained intact. We can thus
safely assume that this complex is of noncovalent
nature. Further control experiments included methanol
or acetic acid induced denaturation of AK both prior to
and after adding Ap5A to the solution. An intact
tertiary structure of the protein is needed to form and
maintain the noncovalent complex. Upon denaturation,
no complexes could be observed (data not shown),
giving additional strong evidence for its specificity.
Finally, it should be confirmed that the inhibitor
binds at the active site of the protein. Therefore, AK was
covalently modified as outlined in the experimental
section. In brief, the active site is blocked by covalently
bound ATP mimic. The resulting sample contained both
modified and unmodified AK which could be differen-
ciated due to their different mass. Figure 3 shows the
mass spectrum of this modified AK sample in the
presence of Ap5A at physiological pH. Almost no
inhibitor binding of the modified AK is observed,
suggesting that the inhibitor Ap5A binds in the active
site of the unmodified protein only. The results of all
control experiments are fully consistent with specific
noncovalent inhibitor binding in the active site of the
Figure 2. Spectrum of 8.8M AK (5 charge state) with a) 8M
Ap4A and b) 8M Ap5A in 50mM (HNEt3)HCO3. The ionization
and the desolvation are very soft, leading to broad peaks. Many
salt and buffer adducts are observed. In the insets Ap4A respec-
tively Ap5A is shown, whereas Ad denotes for adenine.
Figure 3. Spectrum of the reaction mixture (10 M total protein) of AK and covalently modified AK
(AK’) with 10M of Ap5A (with respect to the total concentration of AK and AK') in 50mM
(HNEt3)HCO3. Almost no binding to AK’ is observed, suggesting that the inhibitor binds in the
binding pocket of the protein.
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protein. The second inhibitor, Ap4A, is much less well
studied than Ap5A. For example, no crystal structure
data exist for AK—Ap4A complexes. For the present
investigation, we assume that Ap4A also froms a simi-
lar complex with AK, as suggested by other studies [41,
42].
For the determination of solution phase binding
constants by mass spectrometry, it is necessary that the
experiment satisfies two conditions. First, the ionization
efficiency of the protein and the complex should be
equal. Second, the noncovalent complex must survive
the ionization process, the transfer into the high vac-
uum, and the acceleration in the TOF instrument. The
first condition is probably fulfilled in the present case:
identical charge distributions were found for the bare
protein and the protein-inhibitor complexes. Also, the
tertiary structure and the mass of the bare protein and
the complex are similar. During the titration experi-
ments, we found the total ionization efficiency to de-
crease with increasing concentration of the inhibitor.
Since we only determine the ratio of the complex and
the bare protein, this has no effect on the titration
results as long as the assumption of equal ionization
efficiencies for both species holds. The second condition
should be satisfied, too. For this particular case, electro-
static and dipolar interactions are involved in the sta-
bilization of the complex [43,44] forces that are expected
to increase upon solvent removal (unlike hydrophobic
interactions that will decrease or even vanish in the gas
phase).
The association constants for the AKApXA system
were determined as described in the “Data Evaluation”
section. The experimentally obtained R-values are plot-
ted against the total inhibitor concentrations used for
the titration. In Figure 4, this plot is shown for both
noncovalent inhibitors. The lines represent a fit for the
association constant obtained with help of eq 6. The
association constant for AK and Ap5A is Ka  4.0  10
7
M1, for AK and Ap4A Ka  9.0  10
4 M1. Because the
Ka value for this particular system depends on the
magnesium concentration of the solution, any remain-
ing magnesium was masked by adding an excess of
EDTA. The relative standard deviations for the titration
points were between 1.6% and 5.0%. The confidence
interval for Ka is difficult to estimate, but it will most
probably be less than one order of magnitude. In Table
1, the values obtained experimentally are compared to
data published in the literature. Values determined by
mass spectrometry for AK from chicken muscle lie in
the same range as literature values for different species
and are therefore in very good agreement. These results
also validate our control experiments and the condi-
tions for the titration. It shows that the selected control
experiments are useful and that the postulated condi-
tions are justifiable.
Conclusions
We have shown the successful determination of solu-
tion phase association constants of noncovalent protein-
inhibitor complexes by ESI mass spectrometry. Mass
spectrometry has great potential for becoming a widely
used method in this area due to its sensitivity and
speed. This method allows screening of drug libraries
with respect to their association constants to a target
protein. In this case, control experiments to confirm the
noncovalent nature and the specificity of the complexes
are only necessary to prevent overestimations of asso-
ciation constants due to unspecific aggregation or cova-
lent binding. For “misses,” such controls will usually
not be necessary. Furthermore, the present analysis
assumes that all complexes formed in solution survive
in the mass spectrometer for the timescale of the mea-
surement, and that the ionization efficiency of the bare
target protein and of the protein-inhibitor complex are
equal. These assumptions are true for the present sys-
Figure 4. Result of the titration experiments of AK with Ap5A
(filled inverted triangle, Ka  4.0  107M1) and AK with Ap4A
(filled circle, Ka  9.0  104M1). The lines are the fitted data with
eq 6.
Table 1. Comparison of the association constants measured and published in the literature
Complex Species Ka [M
1] Reference
AK1-Ap4A Chicken muscle 9.0  104 This work
AKe-MgAp4A Escherichia coli 2.3  104 Reinstein et al. [34]
AKe-Ap4A Escherichia coli 7.7  104 Reinstein et al. [34]
AK1-MgAp4A Pig muscle 9.1  104 Feldhaus et al. [42]
AK1-Ap5A Chicken muscle 4.0  107 This work
AKe-MgAp5A Escherichia coli 6.7  107 Reinstein et al. [34]
AKe-AP5A Escherichia coli 1.0  107 Reinstein et al. [34]
AK1-MgAp5A Rabbit muscle 2.8–5.0  108 Lienhard et al. [45]
AK1-MgAp5A Pig muscle 3.4  107 Feldhaus et al. [42]
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tem, but must be validated when investigating un-
known systems.
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